The nation of Zimbabwe has declined a substantial American health deal worth 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on confidential information.
The decision was revealed following a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
An official representative later stated that the United States was requesting genetic material for research and commercial purposes but was unwilling to share the benefits from any future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for continued dialogue to find a agreement agreeable to both sides so the nation's vital HIV programme can be sustained.
Broader Background
This development follows a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the security of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance transparency and responsibility.
As per statements, Sixteen African countries have so far signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy via American-funded initiatives," the Ambassador said.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," he stated.
"In essence, our nation would provide the basic resources for medical research with no certainty that the resulting innovations would be accessible to our population if a new disease outbreak arise."
National Interest and International Frameworks
He also said that the American exit from the global health body and its push of bilateral health agreements were undermining frameworks already established via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.
"This framework is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," he added.
"We are open to ongoing discussions with our US partners on how future collaboration might be designed in a manner that honours the independence and interests of both nations."
Medical Community Reaction
A leading public health body said it understood the government's concerns, but suggested that talks need to persist considering much of the nation's Aids initiatives were funded by international support.
"If technical issues exist, including those involving information security or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it added.
This impasse highlights the continuing tensions between receiving crucial international aid and safeguarding a country's data in an ever more data-driven world.